Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Report Changes To WHO Prequalified IVDs Or Get Dropped From List, Guidance Says

This article was originally published in SRA

Executive Summary

The World Health Organization has issued draft guidance on what changes relating to IVDs that fall under its prequalification program manufacturers must report to the WHO, what changes do not need reporting, and what changes might require a new application for prequalification1.

You may also be interested in...



WHO Plans New Fees For IVD Prequalification In Early 2018

A new fee structure for the prequalification of in vitro diagnostics by the World Health Organization is expected to come into effect in early 2018 following the introduction of a fee-for-service framework for medicines and vaccines in January 2017.

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.

New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with seven new products including Roche's Polivy for treating diffuse large B-cell lymphoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

UsernamePublicRestriction

Register

MT040718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel